Conference Coverage: ESMO 2022 – Focus on GU
Impact of recent ESMO data on clinical practice and therapy guidance in genitourinary cancer
FACULTY CHAIR
Daniel Petrylak, MD
Yale Cancer Center, New Haven, CT, USA
Faculty Members
Susan Slovin, MD, PhD
Memorial Sloan Kettering Cancer Center, New York, NY, USA
Leonard G. Gomella, MD, FACS
Sidney Kimmel Cancer Center, Philadelphia, PA, USA
Robert Dreicer, MD, MACP, FASCO
University of Virginia Cancer Center, Charlottesville, VA, USA
Scott Tagawa, MD, FACP
Weill Cornell Medicine, New York, NY, USA
Thomas Powles, MD, MBBS, MRCP
Barts Cancer Centre, London, United Kingdom
Karim Fizazi, MD, PhD
Gustave Roussy Institute, Villejuif, France
José Pablo Maroto Rey, MD, PhD
Hospital de Sant Pau, Barcelona, Spain
KEY TAKEAWAYS AND STRATEGIC INSIGHTS
- Localized and Metastatic Castration-Sensitive Prostate Cancer
- Metastatic Castration-Resistant Prostate Cancer
- Nonmuscle-Invasive Bladder Cancer and Muscle-Invasive Bladder Cancer
- Locally Advanced and Metastatic Bladder Cancer
- Renal Cell Carcinoma
